Physician profile
Matthew Orgill
NPI 1073091294
$2,549.35
in general payments reported to CMS, 2019-2025
11 companies · $413 in 2025
The $413 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $76.54 · 2024: $2,059 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,214 · Food and Beverage: $886 · Consulting Fee: $300 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,213.73 |
| Food and Beverage | $885.62 |
| Consulting Fee | $300.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,695.28 | 2024-2025 | Air Optix, Systane |
| Johnson & Johnson Vision Care, INC. | $241.90 | 2024-2025 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $196.19 | 2024 | |
| Coopervision INC. | $150.00 | 2024-2025 | Clariti Contact Lens |
| Dompe US, INC. | $67.65 | 2024 | Oxervate |
| Biotissue Holdings INC. | $51.34 | 2024 | |
| Glaukos Corporation | $48.96 | 2024 | Ce-Marked Kxla System |
| Johnson & Johnson Surgical Vision, INC. | $37.33 | 2023 | Lipiflow System Activator (Disposable) |
| Abbvie INC. | $24.23 | 2023 | |
| Oyster Point Pharma, INC. | $21.49 | 2025 | Tyrvaya, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $14.98 | 2023 | Cequa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Orgill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.